{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T10:06:50Z","timestamp":1784110010444,"version":"3.55.0"},"reference-count":161,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T00:00:00Z","timestamp":1630627200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62103436"],"award-info":[{"award-number":["62103436"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Combination therapy has shown an obvious efficacy on complex diseases and can greatly reduce the development of drug resistance. However, even with high-throughput screens, experimental methods are insufficient to explore novel drug combinations. In order to reduce the search space of drug combinations, there is an urgent need to develop more efficient computational methods to predict novel drug combinations. In recent decades, more and more machine learning (ML) algorithms have been applied to improve the predictive performance. The object of this study is to introduce and discuss the recent applications of ML methods and the widely used databases in drug combination prediction. In this study, we first describe the concept and controversy of synergism between drug combinations. Then, we investigate various publicly available data resources and tools for prediction tasks. Next, ML methods including classic ML and deep learning methods applied in drug combination prediction are introduced. Finally, we summarize the challenges to ML methods in prediction tasks and provide a discussion on future work.<\/jats:p>","DOI":"10.1093\/bib\/bbab355","type":"journal-article","created":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T15:27:12Z","timestamp":1630942032000},"source":"Crossref","is-referenced-by-count":119,"title":["Machine learning methods, databases and tools for drug combination prediction"],"prefix":"10.1093","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9611-4488","authenticated-orcid":false,"given":"Lianlian","family":"Wu","sequence":"first","affiliation":[{"name":"Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Wen","sequence":"additional","affiliation":[{"name":"Beijing Institute of Radiation Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjin","family":"Leng","sequence":"additional","affiliation":[{"name":"Beijing Institute of Radiation Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Radiation Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Dai","sequence":"additional","affiliation":[{"name":"College of Life Science and Technology, Beijing University of Chemical Technology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongming","family":"Wang","sequence":"additional","affiliation":[{"name":"Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqi","family":"Liu","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Proteomics, Beijing Proteome Research Center, National Center for Protein Sciences (Beijing), Beijing Institute of Lifeomics, AMMS, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowei","family":"Yan","sequence":"additional","affiliation":[{"name":"Beijing Institute of Radiation Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Radiation Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medicine, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4136-6151","authenticated-orcid":false,"given":"Song","family":"He","sequence":"additional","affiliation":[{"name":"Beijing Institute of Radiation Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1911-7922","authenticated-orcid":false,"given":"Xiaochen","family":"Bo","sequence":"additional","affiliation":[{"name":"Beijing Institute of Radiation Medicine, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"issue":"6","key":"2022011920510215000_ref1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2022011920510215000_ref2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrd2683","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2022011920510215000_ref3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/biostatistics\/kxx069","article-title":"Estimation of clinical trial success rates and related parameters","volume":"20","author":"Wong","year":"2019","journal-title":"Biostatistics"},{"issue":"1","key":"2022011920510215000_ref4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrclinonc.2016.96","article-title":"Combine and conquer: challenges for targeted therapy combinations in early phase trials","volume":"14","author":"Lopez","year":"2017","journal-title":"Nature Nat Rev Clin Oncol"},{"issue":"10","key":"2022011920510215000_ref5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/bioinformatics\/btu046","article-title":"Combinatorial therapy discovery using mixed integer linear programming","volume":"30","author":"Pang","year":"2014","journal-title":"Bioinformatics"},{"issue":"11","key":"2022011920510215000_ref6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat Chem Biol"},{"issue":"1","key":"2022011920510215000_ref7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin Transl Med"},{"issue":"6","key":"2022011920510215000_ref8","first-page":"1172","article-title":"Advances in computational approaches in identifying synergistic drug combinations","volume":"19","author":"Sheng","year":"2017","journal-title":"Brief Bioinform"},{"issue":"7","key":"2022011920510215000_ref9","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cell.2017.11.009","article-title":"Combination cancer therapy can confer benefit via patient-to-patient variability without drug additivity or synergy","volume":"171","author":"Palmer","year":"2017","journal-title":"Cell"},{"issue":"1","key":"2022011920510215000_ref10","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1038\/s41467-020-16735-2","article-title":"A cancer drug atlas enables synergistic targeting of independent drug vulnerabilities","volume":"11","author":"Narayan","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"2022011920510215000_ref11","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.3390\/cancers6031769","article-title":"Drug resistance in cancer: an overview","volume":"6","author":"Housman","year":"2014","journal-title":"Cancer"},{"issue":"5536","key":"2022011920510215000_ref12","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1126\/science.293.5536.1793","article-title":"Structure of MsbA from E. coli: a homolog of the multidrug resistance ATP binding cassette (ABC) transporters","volume":"293","author":"Chang","year":"2001","journal-title":"Science"},{"issue":"12","key":"2022011920510215000_ref13","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/ng.2822","article-title":"ESR1 ligand-binding domain mutations in hormone-resistant breast cancer","volume":"45","author":"Toy","year":"2013","journal-title":"Nat Genet"},{"issue":"9","key":"2022011920510215000_ref14","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1158\/1078-0432.CCR-13-1610","article-title":"Molecular pathways: resistance to kinase inhibitors and implications for therapeutic strategies","volume":"20","author":"Lovly","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"19","key":"2022011920510215000_ref15","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1021\/jm5006463","article-title":"Polypharmacology: challenges and opportunities in drug discovery","volume":"57","author":"Anighoro","year":"2014","journal-title":"J Med Chem"},{"issue":"2","key":"2022011920510215000_ref16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bib\/bbw104","article-title":"Predictive approaches for drug combination discovery in cancer","volume":"19","author":"Madani Tonekaboni","year":"2018","journal-title":"Brief Bioinform"},{"issue":"3","key":"2022011920510215000_ref17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"12","key":"2022011920510215000_ref18","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s42256-019-0122-4","article-title":"Prediction of drug combination effects with a minimal set of experiments","volume":"1","author":"Ianevski","year":"2019","journal-title":"Nat Mach Intell"},{"issue":"10","key":"2022011920510215000_ref19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/nrc3599","article-title":"Cancer drug resistance: an evolving paradigm","volume":"13","author":"Holohan","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"2022011920510215000_ref20","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/bioinformatics\/btx806","article-title":"Deep synergy: predicting anti-cancer drug synergy with deep learning","volume":"34","author":"Preuer","year":"2018","journal-title":"Bioinformatics"},{"issue":"7","key":"2022011920510215000_ref21","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nbt.1549","article-title":"Synergistic drug combinations tend to improve therapeutically relevant selectivity","volume":"27","author":"Leh, Aacute, R J, 2","year":"2009","journal-title":"Nat Biotechnol"},{"issue":"11","key":"2022011920510215000_ref22","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nbt.2391","article-title":"Systematic identification of synergistic drug pairs targeting HIV","volume":"30","author":"Tan","year":"2012","journal-title":"Nat Biotechnol"},{"issue":"12","key":"2022011920510215000_ref23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002323","article-title":"Prediction of drug combinations by integrating molecular and pharmacological data","volume":"7","author":"Zhao","year":"2011","journal-title":"PLoS Comput Biol"},{"issue":"5","key":"2022011920510215000_ref24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrd1086","article-title":"Hit and lead generation: beyond high-throughput screening","volume":"2","author":"Bleicher","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"10","key":"2022011920510215000_ref25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/psp4.12104","article-title":"Systematic analysis of quantitative logic model ensembles predicts drug combination effects on cell signaling networks","volume":"5","author":"Morris","year":"2016","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"2022011920510215000_ref26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/wsbm.51","article-title":"Systems approaches and algorithms for discovery of combinatorial therapies","volume":"2","author":"Feala","year":"2010","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"issue":"39","key":"2022011920510215000_ref27","doi-asserted-by":"crossref","first-page":"63995","DOI":"10.18632\/oncotarget.11745","article-title":"Modeling of signaling crosstalk-mediated drug resistance and its implications on drug combination","volume":"7","author":"Sun","year":"2016","journal-title":"Oncotarget"},{"issue":"12","key":"2022011920510215000_ref28","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/nbt.3052","article-title":"A community computational challenge to predict the activity of pairs of compounds","volume":"32","author":"Bansal","year":"2014","journal-title":"Nat Biotechnol"},{"issue":"8","key":"2022011920510215000_ref29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042573","article-title":"CDA: combinatorial drug discovery using transcriptional response modules","volume":"7","author":"Lee","year":"2012","journal-title":"Plos One"},{"issue":"3","key":"2022011920510215000_ref30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1158\/1535-7163.MCT-08-0937","article-title":"Algorithmic guided screening of drug combinations of arbitrary size for activity against cancer cells","volume":"8","author":"Zinner","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2022011920510215000_ref31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/psp4.12491","article-title":"Machine learning in drug discovery and development part 1: a primer","volume":"9","author":"Talevi","year":"2020","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"10","key":"2022011920510215000_ref32","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s42256-020-00236-4","article-title":"Drug discovery with explainable artificial intelligence","volume":"2","author":"Jim\u00e9nez-Luna","year":"2020","journal-title":"Nat Mach Intell"},{"issue":"4","key":"2022011920510215000_ref33","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/bib\/bby004","article-title":"Artificial intelligence in drug combination therapy","volume":"20","author":"Tsigelny","year":"2019","journal-title":"Brief Bioinform"},{"issue":"1","key":"2022011920510215000_ref34","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09799-2","article-title":"Community assessment to advance computational prediction of cancer drug combinations in a pharmacogenomic screen","volume":"10","author":"Menden","year":"2019","journal-title":"Nat Commun"},{"issue":"1","key":"2022011920510215000_ref35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"2022011920510215000_ref36","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2019.00509","article-title":"Predicting synergism of cancer drug combinations using NCI-ALMANAC data","volume":"7","author":"Sidorov","year":"2019","journal-title":"Front Chem"},{"issue":"12","key":"2022011920510215000_ref37","doi-asserted-by":"crossref","first-page":"i228","DOI":"10.1093\/bioinformatics\/btu278","article-title":"Drug combo ranker: drug combination discovery based on target network analysis","volume":"30","author":"Huang","year":"2014","journal-title":"Bioinformatics"},{"key":"2022011920510215000_ref38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9481","article-title":"Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer","volume":"6","author":"Sun","year":"2015","journal-title":"Nat Commun"},{"issue":"7","key":"2022011920510215000_ref39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004975","article-title":"NLLSS: predicting synergistic drug combinations based on semi-supervised learning","volume":"12","author":"Chen","year":"2016","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"2022011920510215000_ref40","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40745-015-0040-1","article-title":"A comprehensive survey of clustering algorithms","volume":"2","author":"Xu","year":"2015","journal-title":"Ann Data Sci"},{"issue":"W1","key":"2022011920510215000_ref41","doi-asserted-by":"crossref","first-page":"W43","DOI":"10.1093\/nar\/gkz337","article-title":"Drug comb: an integrative cancer drug combination data portal","volume":"47","author":"Zagidullin","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"13","key":"2022011920510215000_ref42","doi-asserted-by":"crossref","first-page":"3564","DOI":"10.1158\/0008-5472.CAN-17-0489","article-title":"The National Cancer Institute ALMANAC: a comprehensive screening resource for the detection of anticancer drug pairs with enhanced therapeutic activity","volume":"77","author":"Holbeck","year":"2017","journal-title":"Cancer Res"},{"key":"2022011920510215000_ref43","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2015.00181","article-title":"What is synergy? The Saariselka agreement revisited","volume":"6","author":"Tang","year":"2015","journal-title":"Front Pharmacol"},{"issue":"11","key":"2022011920510215000_ref44","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1080\/10428190802353591","article-title":"Preclinical versus clinical drug combination studies","volume":"49","author":"Chou","year":"2008","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"2022011920510215000_ref45","article-title":"Statistical determination of synergy based on Bliss definition of drugs independence","volume":"14","author":"Englehardt","year":"2019","journal-title":"Plos One"},{"issue":"6","key":"2022011920510215000_ref46","first-page":"285","article-title":"The problem of synergism and antagonism of combined drugs","volume":"3","author":"Loewe","year":"1953","journal-title":"Arzneimittelforschung"},{"key":"2022011920510215000_ref47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann Appl Biol"},{"issue":"2","key":"2022011920510215000_ref48","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1213\/ane.0b013e31817b7140","article-title":"Additivity versus synergy: a theoretical analysis of implications for anesthetic mechanisms","volume":"107","author":"Shafer","year":"2008","journal-title":"Anesth Anal"},{"issue":"11","key":"2022011920510215000_ref49","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nrmicro3351","article-title":"A mechanistic theory to explain the efficacy of antiretroviral therapy","volume":"12","author":"Laskey","year":"2014","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"2022011920510215000_ref50","doi-asserted-by":"crossref","first-page":"807","DOI":"10.15252\/msb.20156098","article-title":"Systematic discovery of drug interaction mechanisms","volume":"11","author":"Chevereau","year":"2015","journal-title":"Mol Syst Biol"},{"issue":"1","key":"2022011920510215000_ref51","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrd1609","article-title":"Multicomponent therapeutics for networked systems","volume":"4","author":"Keith","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"2022011920510215000_ref52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2022011920510215000_ref53","first-page":"331","article-title":"The search for synergy: a critical review from a response surface perspective","volume":"47","author":"Greco","year":"1995","journal-title":"Pharmacol Rev"},{"key":"2022011920510215000_ref54","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0165-6147(83)90490-X","article-title":"Analysis of combined drug effects: a new look at a very old problem","volume":"4","author":"Chou","year":"1983","journal-title":"Trends Pharmacol Sci"},{"issue":"13","key":"2022011920510215000_ref55","doi-asserted-by":"crossref","first-page":"7977","DOI":"10.1073\/pnas.1337088100","article-title":"Systematic discovery of multicomponent therapeutics","volume":"100","author":"Borisy","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022011920510215000_ref56","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.csbj.2015.09.001","article-title":"Searching for drug synergy in complex dose\u2013response landscapes using an interaction potency model","volume":"13","author":"Yadav","year":"2015","journal-title":"Comput Struct Biotechnol J"},{"key":"2022011920510215000_ref57","article-title":"Drug comb update: a more comprehensive drug sensitivity data repository and analysis portal","volume":"1","author":"Zheng","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2022011920510215000_ref58","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40537-020-00369-8","article-title":"CatBoost for big data: an interdisciplinary review","volume":"7","author":"Hancock","year":"2020","journal-title":"J Big Data"},{"issue":"D1","key":"2022011920510215000_ref59","first-page":"D871","article-title":"DrugCombDB: a comprehensive database of drug combinations toward the discovery of combinatorial therapy","volume":"48","author":"Liu","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"2022011920510215000_ref60","doi-asserted-by":"crossref","first-page":"422","DOI":"10.2174\/092986708783503212","article-title":"From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage","volume":"15","author":"Giordano","year":"2008","journal-title":"Curr Med Chem"},{"issue":"W1","key":"2022011920510215000_ref61","doi-asserted-by":"crossref","first-page":"W494","DOI":"10.1093\/nar\/gkaa421","article-title":"SYNERGxDB: an integrative pharmacogenomic portal to identify synergistic drug combinations for precision oncology","volume":"48","author":"Haibe-Kains","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"2022011920510215000_ref62","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/1535-7163.MCT-15-0843","article-title":"An unbiased oncology compound screen to identify novel combination strategies","volume":"15","author":"O'neil","year":"2016","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"2022011920510215000_ref63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086499","article-title":"ASDCD: antifungal synergistic drug combination database","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"2022011920510215000_ref64","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/bioinformatics\/btp697","article-title":"DCDB: drug combination database","volume":"26","author":"Liu","year":"2010","journal-title":"Bioinformatics"},{"key":"2022011920510215000_ref65","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bau124","article-title":"DCDB 2.0: a major update of the drug combination database","volume":"2014","author":"Liu","year":"2014","journal-title":"Database"},{"issue":"D1","key":"2022011920510215000_ref66","doi-asserted-by":"crossref","first-page":"D1121","DOI":"10.1093\/nar\/gkx1076","article-title":"Therapeutic target database update 2018: enriched resource for facilitating bench-to-clinic research of targeted therapeutics","volume":"46","author":"Zhu","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2022011920510215000_ref67","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.compbiomed.2019.05.006","article-title":"DrugR+: a comprehensive relational database for drug repurposing, combination therapy, and replacement therapy","volume":"109","author":"Masoudi-Sobhanzadeh","year":"2019","journal-title":"Comput Biol Med"},{"key":"2022011920510215000_ref68","first-page":"351","article-title":"Methods for high-throughput drug combination screening and synergy scoring","volume":"2018","author":"He","year":"1711","journal-title":"Methods Mol Biol"},{"issue":"15","key":"2022011920510215000_ref69","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","article-title":"SynergyFinder: a web application for analyzing drug combination dose\u2013response matrix data","volume":"33","author":"Ianevski","year":"2017","journal-title":"Bioinformatics"},{"issue":"W1","key":"2022011920510215000_ref70","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Aittokallio","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2022011920510215000_ref71","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1093\/bioinformatics\/btaa826","article-title":"Synergy: a python library for calculating, analyzing and visualizing drug combination synergy","volume":"37","author":"Wooten","year":"2021","journal-title":"Bioinformatics"},{"issue":"9 Supplement","key":"2022011920510215000_ref72","first-page":"637","article-title":"The mass-action law-based new computer software, CompuSyn, for automated simulation of synergism and antagonism in drug combination studies","volume":"67","author":"Chou","year":"2007","journal-title":"Cancer Res"},{"issue":"18","key":"2022011920510215000_ref73","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1093\/bioinformatics\/btw230","article-title":"Combenefit: an interactive platform for the analysis and visualization of drug combinations","volume":"32","author":"Di Veroli","year":"2016","journal-title":"Bioinformatics"},{"issue":"12","key":"2022011920510215000_ref74","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1038\/nbt1206-1565","article-title":"What is a support vector machine?","volume":"24","author":"Noble","year":"2006","journal-title":"Nat Biotechnol"},{"issue":"3","key":"2022011920510215000_ref75","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1109\/21.97458","article-title":"A survey of decision tree classifier methodology","volume":"21","author":"Safavian","year":"1991","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"2022011920510215000_ref76","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1145\/2939672.2939785","article-title":"XGBoost: a scalable tree boosting system","volume-title":"Kdd'16: Proceedings of the 22nd Acm Sigkdd International Conference on Knowledge Discovery and Data Mining","author":"Chen","year":"2016"},{"key":"2022011920510215000_ref77","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neunet.2014.09.003","article-title":"Deep learning in neural networks: an overview","volume":"61","author":"Schmidhuber","year":"2015","journal-title":"Neural Netw"},{"key":"2022011920510215000_ref78","doi-asserted-by":"crossref","DOI":"10.1109\/ICAIOT.2015.7111524","article-title":"Deep belief networks and deep learning","volume-title":"Proceedings of 2015 International Conference on Intelligent Computing and Internet of Things, F 17-18","author":"Yuming","year":"2015"},{"issue":"2","key":"2022011920510215000_ref79","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/aic.690370209","article-title":"Nonlinear principal component analysis using autoassociative neural networks","volume":"37","author":"Kramer","year":"1991","journal-title":"AIChE J"},{"key":"2022011920510215000_ref80","article-title":"Explainable machine learning prediction of synergistic drug combinations for precision cancer medicine","author":"Janizek","year":"2018","journal-title":"bioRxiv"},{"issue":"1","key":"2022011920510215000_ref81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1005308","article-title":"A computational approach for identifying synergistic drug combinations","volume":"13","author":"Gayvert","year":"2017","journal-title":"PLoS Comput Biol"},{"key":"2022011920510215000_ref82","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jtbi.2017.01.019","article-title":"PDC-SGB: prediction of effective drug combinations using a stochastic gradient boosting algorithm","volume":"417","author":"Xu","year":"2017","journal-title":"J Theor Biol"},{"issue":"5","key":"2022011920510215000_ref83","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/bib\/bby061","article-title":"Recent applications of deep learning and machine intelligence on in silico drug discovery: methods, tools and databases","volume":"20","author":"Rifaioglu","year":"2019","journal-title":"Brief Bioinform"},{"issue":"4","key":"2022011920510215000_ref84","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s40484-016-0081-2","article-title":"Performance measures in evaluating machine learning based bioinformatics predictors for classifications","volume":"4","author":"Jiao","year":"2016","journal-title":"Quant Biol"},{"issue":"5","key":"2022011920510215000_ref85","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1532-0464(03)00034-0","article-title":"Logistic regression and artificial neural network classification models: a methodology review","volume":"35","author":"Dreiseitl","year":"2002","journal-title":"J Biomed Inform"},{"key":"2022011920510215000_ref86","doi-asserted-by":"crossref","DOI":"10.1109\/ICDM.2010.127","article-title":"Factorization machines","volume-title":"2010 IEEE International Conference on Data Mining","author":"Rendle","year":"2010"},{"issue":"4","key":"2022011920510215000_ref87","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0167-9473(01)00065-2","article-title":"Stochastic gradient boosting","volume":"38","author":"Friedman","year":"2002","journal-title":"Comput Stat Data Anal"},{"key":"2022011920510215000_ref88","first-page":"713","volume-title":"Na\u00efve Bayes. Encyclopedia of Machine Learning","author":"Webb","year":"2010"},{"key":"2022011920510215000_ref89","first-page":"217","volume-title":"Logistic Regression. Reading and Understanding Multivariate Statistics","author":"Wright","year":"1995"},{"key":"2022011920510215000_ref90","doi-asserted-by":"crossref","first-page":"196858","DOI":"10.1155\/2014\/196858","article-title":"A hadoop-based method to predict potential effective drug combination","volume":"2014","author":"Sun","year":"2014","journal-title":"Biomed Res Int"},{"key":"2022011920510215000_ref91","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3389\/fgene.2020.01000","article-title":"A machine learning method for drug combination prediction","volume":"11","author":"Li","year":"2020","journal-title":"Front Genet"},{"key":"2022011920510215000_ref92","doi-asserted-by":"crossref","DOI":"10.1201\/b12207","volume-title":"Ensemble Methods: Foundations and Algorithms","author":"Zhou","year":"2012"},{"key":"2022011920510215000_ref93","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.talanta.2013.04.031","article-title":"Development and validation of a general approach to predict and quantify the synergism of anti-cancer drugs using experimental design and artificial neural networks","volume":"115","author":"Pivetta","year":"2013","journal-title":"Talanta"},{"key":"2022011920510215000_ref94","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19950-z","article-title":"Leveraging multiway interactions for systematic prediction of pre-clinical drug combination effects","volume":"11","author":"Julkunen","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"2022011920510215000_ref95","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1109\/MCAS.2006.1688199","article-title":"Ensemble based systems in decision making","volume":"6","author":"Polikar","year":"2006","journal-title":"IEEE Circuits Syst Mag"},{"issue":"2","key":"2022011920510215000_ref96","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/BF00058655","article-title":"Bagging predictors","volume":"24","author":"Breiman","year":"1996","journal-title":"Machine Learning"},{"issue":"6","key":"2022011920510215000_ref97","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cels.2015.12.003","article-title":"Prediction of synergism from chemical-genetic interactions by machine learning","volume":"1","author":"Wildenhain","year":"2015","journal-title":"Cell Syst"},{"key":"2022011920510215000_ref98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/839761","article-title":"Prediction of effective drug combinations by chemical interaction, protein interaction and target enrichment of KEGG pathways","volume":"2013","author":"Chen","year":"2013","journal-title":"Biomed Res Int"},{"issue":"1","key":"2022011920510215000_ref99","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12936-018-2294-5","article-title":"A systematic and prospectively validated approach for identifying synergistic drug combinations against malaria","volume":"17","author":"Kalantarmotamedi","year":"2018","journal-title":"Malar J"},{"key":"2022011920510215000_ref100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.artmed.2017.05.008","article-title":"Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles","volume":"83","author":"Li","year":"2017","journal-title":"Artif Intell Med"},{"issue":"6","key":"2022011920510215000_ref101","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02627-19","article-title":"Transcriptomic signatures predict regulators of drug synergy and clinical regimen efficacy against tuberculosis","volume":"10","author":"Ma","year":"2019","journal-title":"MBio"},{"issue":"9","key":"2022011920510215000_ref102","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1158\/0008-5472.CAN-17-3644","article-title":"Patient-customized drug combination prediction and testing for T-cell prolymphocytic leukemia patients","volume":"78","author":"He","year":"2018","journal-title":"Cancer Res"},{"issue":"1","key":"2022011920510215000_ref103","article-title":"Machine learning with statistical imputation for predicting drug approval","volume":"1","author":"Lo","year":"2019","journal-title":"Harvard Data Sci Rev"},{"issue":"2","key":"2022011920510215000_ref104","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/bib\/bbx124","article-title":"Evaluation of variable selection methods for random forests and omics data sets","volume":"20","author":"Degenhardt","year":"2019","journal-title":"Brief Bioinform"},{"issue":"4","key":"2022011920510215000_ref105","doi-asserted-by":"crossref","DOI":"10.3390\/s16040592","article-title":"Electromyographic patterns during golf swing: activation sequence profiling and prediction of shot effectiveness","volume":"16","author":"Verikas","year":"2016","journal-title":"Sensors"},{"issue":"1","key":"2022011920510215000_ref106","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12859-016-1415-9","article-title":"Predicting potential drug-drug interactions by integrating chemical, biological, phenotypic and network data","volume":"18","author":"Zhang","year":"2017","journal-title":"BMC Bioinformatics"},{"key":"2022011920510215000_ref107","doi-asserted-by":"crossref","first-page":"603615","DOI":"10.3389\/fimmu.2020.603615","article-title":"Indicator regularized non-negative matrix factorization method-based drug repurposing for COVID-19","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"key":"2022011920510215000_ref108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmpb.2018.11.002","article-title":"Predicting combinative drug pairs via multiple classifier system with positive samples only","volume":"168","author":"Shi","year":"2019","journal-title":"Comput Methods Programs Biomed"},{"key":"2022011920510215000_ref109","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3389\/fnbot.2013.00021","article-title":"Gradient boosting machines, a tutorial","volume":"7","author":"Natekin","year":"2013","journal-title":"Front Neurorobot"},{"key":"2022011920510215000_ref110","first-page":"4765","article-title":"A unified approach to interpreting model predictions","author":"Lundberg","year":"2017","journal-title":"Adv Neur In"},{"issue":"1","key":"2022011920510215000_ref111","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/bib\/bbz171","article-title":"Deep learning for drug response prediction in cancer","volume":"22","author":"Baptista","year":"2021","journal-title":"Brief Bioinform"},{"issue":"2","key":"2022011920510215000_ref112","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/bib\/bbaa257","article-title":"Biological network analysis with deep learning","volume":"22","author":"Muzio","year":"2021","journal-title":"Brief Bioinform"},{"key":"2022011920510215000_ref113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1109\/TCBB.2021.3086702","article-title":"MatchMaker: a deep learning framework for drug synergy prediction","author":"Kuru","year":"2021","journal-title":"IEEE\/ACM Trans Comput Biol Bioinform"},{"issue":"1","key":"2022011920510215000_ref114","first-page":"643","article-title":"Learning algorithms for the classification restricted Boltzmann machine","volume":"13","author":"Larochelle","year":"2012","journal-title":"J Mach Learn Res"},{"issue":"7","key":"2022011920510215000_ref115","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1162\/neco.2006.18.7.1527","article-title":"A fast learning algorithm for deep belief nets","volume":"18","author":"Hinton","year":"2006","journal-title":"Neural Comput"},{"key":"2022011920510215000_ref116","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jbi.2018.07.024","article-title":"Predict effective drug combination by deep belief network and ontology fingerprints","volume":"85","author":"Chen","year":"2018","journal-title":"J Biomed Inform"},{"key":"2022011920510215000_ref117","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/978-1-0716-0849-4_12","article-title":"Synergistic drug combination prediction by integrating multiomics data in deep learning models","volume":"2194","author":"Zhang","year":"2021","journal-title":"Methods Mol Biol"},{"key":"2022011920510215000_ref118","volume-title":"Semi-Supervised Classification with Graph Convolutional Networks","author":"Kipf","year":"2016"},{"key":"2022011920510215000_ref119","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1021\/acs.jcim.9b00628","article-title":"Graph convolutional neural networks for predicting drug-target interactions","volume":"59","author":"Torng","year":"2019","journal-title":"J Chem Inf Model"},{"issue":"13","key":"2022011920510215000_ref120","doi-asserted-by":"crossref","first-page":"i457","DOI":"10.1093\/bioinformatics\/bty294","article-title":"Modeling polypharmacy side effects with graph convolutional networks","volume":"34","author":"Zitnik","year":"2018","journal-title":"Bioinformatics"},{"key":"2022011920510215000_ref121","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.csbj.2020.02.006","article-title":"Deep graph embedding for prioritizing synergistic anticancer drug combinations","volume":"18","author":"Jiang","year":"2020","journal-title":"Comput Struct Biotechnol J"},{"issue":"5","key":"2022011920510215000_ref122","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ccell.2020.09.014","article-title":"Predicting drug response and synergy using a deep learning model of human cancer cells","volume":"38","author":"Kuenzi","year":"2020","journal-title":"Cancer Cell"},{"issue":"9","key":"2022011920510215000_ref123","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/sj.bjc.6602553","article-title":"Phase I and pharmacokinetic study of the novel chemoprotector BNP7787 in combination with cisplatin and attempt to eliminate the hydration schedule","volume":"92","author":"Boven","year":"2005","journal-title":"Br J Cancer"},{"issue":"5","key":"2022011920510215000_ref124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006752","article-title":"Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer","volume":"15","author":"Malyutina","year":"2019","journal-title":"PLoS Comput Biol"},{"issue":"7","key":"2022011920510215000_ref125","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/s41589-020-0510-4","article-title":"Drug antagonism and single-agent dominance result from differences in death kinetics","volume":"16","author":"Richards","year":"2020","journal-title":"Nat Chem Biol"},{"key":"2022011920510215000_ref126","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.omtn.2019.05.017","article-title":"Anticancer drug response prediction in cell lines using weighted graph regularized matrix factorization","volume":"17","author":"Guan","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"2022011920510215000_ref127","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.omtn.2018.09.011","article-title":"Anti-cancer drug response prediction using neighbor-based collaborative filtering with global effect removal","volume":"13","author":"Liu","year":"2018","journal-title":"Mol Ther - Nucleic Acids"},{"issue":"1","key":"2022011920510215000_ref128","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/msb.2008.60","article-title":"Finding multiple target optimal intervention in disease-related molecular network","volume":"4","author":"Yang","year":"2008","journal-title":"Mol Syst Biol"},{"issue":"1","key":"2022011920510215000_ref129","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41467-019-09186-x","article-title":"Network-based prediction of drug combinations","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"2022011920510215000_ref130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003226","article-title":"Target inhibition networks: predicting selective combinations of Druggable targets to block cancer survival pathways","volume":"9","author":"Tang","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"2022011920510215000_ref131","first-page":"1482","article-title":"Prediction of synergistic drug combinations by learning from deep representations of multiple networks","volume":"264","author":"Hu","year":"2019","journal-title":"Stud Health Technol Inform"},{"key":"2022011920510215000_ref132","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1038\/srep07160","article-title":"Systematic prediction of drug combinations based on clinical side-effects","volume":"4","author":"Huang","year":"2014","journal-title":"Sci Rep"},{"issue":"Suppl 12","key":"2022011920510215000_ref133","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12859-017-1818-2","article-title":"Predicting combinative drug pairs towards realistic screening via integrating heterogeneous features","volume":"18","author":"Shi","year":"2017","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"2022011920510215000_ref134","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1021\/acs.jcim.6b00591","article-title":"Extreme gradient boosting as a method for quantitative structure\u2013activity relationships","volume":"56","author":"Sheridan","year":"2016","journal-title":"J Chem Inf Model"},{"key":"2022011920510215000_ref135","doi-asserted-by":"crossref","first-page":"600","DOI":"10.3389\/fgene.2019.00600","article-title":"Five-feature model for developing the classifier for synergistic vs. antagonistic drug combinations built by XGBoost","volume":"10","author":"Ji","year":"2019","journal-title":"Front Genet"},{"issue":"1","key":"2022011920510215000_ref136","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1186\/s12859-019-3288-1","article-title":"Predicting effective drug combinations using gradient tree boosting based on features extracted from drug-protein heterogeneous network","volume":"20","author":"Liu","year":"2019","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"2022011920510215000_ref137","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.synbio.2018.10.002","article-title":"Synergistic drug combinations prediction by integrating pharmacological data","volume":"4","author":"Zhang","year":"2019","journal-title":"Synth Syst Biotechnol"},{"issue":"D1","key":"2022011920510215000_ref138","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"2022011920510215000_ref139","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/s41587-020-0502-7","article-title":"Extending the small-molecule similarity principle to all levels of biology with the chemical checker","volume":"38","author":"Duran-Frigola","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"2022011920510215000_ref140","doi-asserted-by":"crossref","first-page":"D380","DOI":"10.1093\/nar\/gkv1277","article-title":"STITCH 5: augmenting protein\u2013chemical interaction networks with tissue and affinity data","volume":"44","author":"Szklarczyk","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2022011920510215000_ref141","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"2022011920510215000_ref142","doi-asserted-by":"crossref","first-page":"D354","DOI":"10.1093\/nar\/gkj102","article-title":"From genomics to chemical genomics: new developments in KEGG","volume":"34","author":"Kanehisa","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"suppl_1","key":"2022011920510215000_ref143","first-page":"D480","article-title":"KEGG for linking genomes to life and the environment","volume":"36","author":"Kanehisa","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2022011920510215000_ref144","doi-asserted-by":"crossref","first-page":"D1075","DOI":"10.1093\/nar\/gkv1075","article-title":"The SIDER database of drugs and side effects","volume":"44","author":"Kuhn","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"125","key":"2022011920510215000_ref145","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003377","article-title":"Data-driven prediction of drug effects and interactions","volume":"4","author":"Tatonetti","year":"2012","journal-title":"Sci Transl Med"},{"issue":"D1","key":"2022011920510215000_ref146","doi-asserted-by":"crossref","first-page":"D1102","DOI":"10.1093\/nar\/gky1033","article-title":"PubChem 2019 update: improved access to chemical data","volume":"47","author":"Kim","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2022011920510215000_ref147","doi-asserted-by":"crossref","first-page":"D506","DOI":"10.1093\/nar\/gky1049","article-title":"UniProt: a worldwide hub of protein knowledge","volume":"47","author":"Uniprot","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"2022011920510215000_ref148","first-page":"D919","article-title":"SuperTarget and matador: resources for exploring drug-target relationships","volume":"36","author":"G\u00fcnther","year":"2008","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2022011920510215000_ref149","doi-asserted-by":"crossref","first-page":"D529","DOI":"10.1093\/nar\/gky1079","article-title":"The BioGRID interaction database: 2019 update","volume":"47","author":"Oughtred","year":"2019","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"2022011920510215000_ref150","doi-asserted-by":"crossref","first-page":"D767","DOI":"10.1093\/nar\/gkn892","article-title":"Human protein reference database--2009 update","volume":"37","author":"Keshava Prasad","year":"2009","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2022011920510215000_ref151","doi-asserted-by":"crossref","first-page":"D431","DOI":"10.1093\/nar\/gkz1023","article-title":"LINCS data portal 2.0: next generation access point for perturbation-response signatures","volume":"48","author":"Stathias","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2022011920510215000_ref152","doi-asserted-by":"crossref","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"2022011920510215000_ref153","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.chembiol.2017.11.009","article-title":"Drug target commons: a community effort to build a consensus knowledge base for drug-target interactions","volume":"25","author":"Tang","year":"2018","journal-title":"Cell Chem Biol"},{"issue":"D1","key":"2022011920510215000_ref154","first-page":"D992","article-title":"TDR targets 6: driving drug discovery for human pathogens through intensive chemogenomic data integration","volume":"48","author":"Berenstein","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2022011920510215000_ref155","doi-asserted-by":"crossref","first-page":"D1098","DOI":"10.1093\/nar\/gkt1143","article-title":"The IUPHAR\/BPS guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands","volume":"42","author":"Pawson","year":"2014","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2022011920510215000_ref156","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/srep01445","article-title":"CancerDR: cancer drug resistance database","volume":"3","author":"Kumar","year":"2013","journal-title":"Sci Rep"},{"issue":"suppl_1","key":"2022011920510215000_ref157","doi-asserted-by":"crossref","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: a web-accessible database of experimentally determined protein\u2013ligand binding affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"2022011920510215000_ref158","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/bioinformatics\/btv067","article-title":"TIMMA-R: an R package for predicting synergistic multi-targeted drug combinations in cancer cell lines or patient-derived samples","volume":"31","author":"He","year":"2015","journal-title":"Bioinformatics"},{"issue":"12","key":"2022011920510215000_ref159","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btv080","article-title":"Large-scale exploration and analysis of drug combinations","volume":"31","author":"Li","year":"2015","journal-title":"Bioinformatics"},{"issue":"1","key":"2022011920510215000_ref160","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1158\/2159-8290.CD-12-0408","article-title":"Genotype-selective combination therapies for melanoma identified by high-throughput drug screening","volume":"3","author":"Held","year":"2013","journal-title":"Cancer Discov"},{"issue":"1","key":"2022011920510215000_ref161","doi-asserted-by":"crossref","first-page":"13891","DOI":"10.1038\/srep13891","article-title":"High-throughput matrix screening identifies synergistic and antagonistic antimalarial drug combinations","volume":"5","author":"Mott","year":"2015","journal-title":"Sci Rep"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/1\/bbab355\/42229728\/bbab355.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/23\/1\/bbab355\/42229728\/bbab355.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T20:53:05Z","timestamp":1642625585000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbab355\/6363058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1,17]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbab355","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1]]},"published":{"date-parts":[[2021,9,2]]},"article-number":"bbab355"}}